Childhood evaluation of salmeterol tolerance - A double-blind randomized controlled trial

Pediatric Allergy and Immunology

Volumn 21, Issue 2 PART 1, 2010, Pages 336-344

  Carroll, W D ^a   Jones, P W ^b   Boit, P ^c   Clayton, S ^c   Cliff, I ^c   Lenney, W ^c  

^a DERBYSHIRE CHILDREN S HOSPITAL   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

Asthma; Beta 2 agonists; Salmeterol; Tachyphylaxis

Indexed keywords

FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; SALBUTAMOL; SALMETEROL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COLD AIR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; DRUG SCREENING; DRUG TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SYMPTOM; TACHYPHYLAXIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; CHILD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; TACHYPHYLAXIS; TREATMENT OUTCOME;

EID: 77950282587     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2009.00927.x     Document Type: Article

References (44)

1. Greening A, Ind P, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994 : 344 : 219 224.
2. Simons FER, Soni NR, Watson NTA, Becker AB. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma. J Allergy Clin Immunol 1992 : 90 : 840 846.
3. Green CP, Price JF. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child 1992 : 67 : 1014 1017.
4. Lenney W, Pedersen S, Boner AL, Ebbutt A, Jenkins MM. Efficacy and safety of salmeterol in childhood asthma. Eur J Pediatr 1995 : 154 : 983 990.
5. Weinstein SF, Pearlman DS, Bronsky EA, et al. Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma. Ann Allergy Asthma Immunol 1998 : 81 : 51 8.
6. Verberne AA, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF. Addition of salmetreol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. Am J Respir Crit Care Med 1998 : 158 : 213 219.
7. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003 : 58 (Suppl. 1 i 1 94.
8. National Heart, Lung, and Blood Institute. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD : National Institute of Health, 1997
9. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention. Bethesda, Md : National Institutes of Health (NIH), 2007 : NIH publication no. 02-3659.
10. Bisgaard H. Long-acting β2-agonists in the management of childhood asthma: a critical review of the literature. Pediatr Pulmonol 2000 : 29 : 221 234.
11. Bisgaard H. Effect of long-acting β2-agonists on exacerbation rates of asthma in children. Pediatr Pulmonol 2003 : 36 : 391 398.
12. Bisgaard H, Szefler S. Long-acting β2 agonists and paediatric asthma. Lancet 2006 : 367 : 286 288.
13. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agoinsts on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006 : 144 : 904 912.
14. Mann M, Chowdhury B, Sullivan E, et al. Serious asthma exacerbations in asthmatics treated with high-dose formoterol. Chest 2003 : 124 : 70 4.
15. Graff-Lonnevig V, Browaldh L. Twelve hours' bronchodilating effect of inhaled formoterol in children with asthma: a double-blind cross-over study versus salbutamol. Clin Exp Allergy 1990 : 20 : 429 432.
16. Verberne AAPH, Hop WC, Creyghton FB, et al. Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma. Am J Allergy Clin Immunol 1996 : 97 : 938 946.
17. Carlsen KH, Roksund O, Olsholt K, et al. Overnight protection by inhaled salmeterol on exercise-induced asthma in children. Eur Respir J 1995 : 8 : 1852 1855.
18. Barbato A, Cracco A, Tomena F, et al. The first 20 minutes after a single dose of inhaled salmeterol in asthmatic children. Allergy 1995 : 50 : 506 510.
19. de Benedictis FM, Tuteri G, Pazzelli P, et al. Salmeterol in exercise-induced bronchoconstriction in asthmatic children: comparison of two doses. Eur Respir J 1996 : 9 : 2099 2103.
20. 2-agonist for their bronchodilating efficacy in the treatment of childhood bronchial asthma. Pediatr Pulmonol 1989 : 7 : 89 93.
21. Henriksen JM, Agertoft L, Pedersen S. Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children. J Allergy Clin Immunol 1992 : 89 : 1176 1182.
22. Daubjerg P, Nielsen KG, Skov M, et al. Duration of action of formoterol and salbutamol dry-powder inhalation in prevention of exercise-induced asthma in children. Acta Paediatr 1996 : 85 : 684 687.
23. Foucard T, Lönnerholm G. A study with cumulative doses of formoterol and salbutamol in children with asthma. Eur Respir J 1991 : 4 : 1174 1177.
24. Boner AL, Spezia E, Piovesan P, et al. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children. Am J Respir Crit Care Med 1994 : 149 : 935 939.
25. Nielsen KG, Skov M, Klug B, et al. Flow-dependent effect of formoterol dry-powder inhaler from the Aerolizer. Eur Respir J 1997 : 10 : 2105 2109.
26. Verberne AAPH, Hop WCJ, Bos AB, et al. Effect of a single dose of inhaled salmeterol on baseline airway calibre and methacholine-induced airway obstruction in asthmatic children. J Allergy Clin Immunol 1993 : 91 : 127 134.
27. Bartow RA, Brogden RN. Formoterol. An update on its pharmacological properties and therapeutic efficacy in the management of asthma. Drugs 1998 : 55 : 303 322.
28. Adkins JC, McTavish D. Salmeterol. A review of it pharmacological properties and clinical efficacy in the management of children with asthma. Drugs 1997 : 54 : 331 354.
29. Booth H, Bish R, Walters J, Whitehead F, Walters EH. Salmeterol tachyphylaxis in steroid treated asthmatic subjects. Thorax 1996 : 51 : 1100 1104.
30. Kalra S, Swystun VA, Bhagat R, Cockcroft DW. Inhaled corticosteroids do not prevent the development of tolerance to the broncho-protective effect of salmeterol. Chest 1996 : 109 : 953 956.
31. Fuglsang G, Vikre-Jorgensen J, Agertoft L, Pedersen S. Effect of salmeterol treatment on nitric oxide level in exhaled air and dose-response to terbutaline in children with mild asthma. Pediatr Pulmonol 1998 : 25 : 314 321.
32. Lee DKC, Jackson CM, Bates CE, Lipworth BJ. Cross tolerance to salbutamol occurs independently of ß2-adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol. Thorax 2004 : 59 : 662 667.
33. Taylor DR, Town GI, Herbison GP, et al. Asthma control during long-term treatment with regular inhaler salbutamol and salmeterol. Thorax 1998 : 53 : 744 752.
34. Wilding L, Clark M, Thompson-Coon J, et al. Effect of long-term treatment with salmeterol on asthma control. Br Med J 1997 : 314 : 1441 1446.
35. Langley SJ, Masterson CM, Batty EP, Woodcock A. Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo. Eur Respir J 1998 : 11 : 1081 1085.
36. Nelson HS, Berkowitz RB, Tinkelman DA, Emmett AH, Rickard KA, Yancey SW. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma. Am J Respir Crit Care Med 1999 : 159 : 1556 1561.
37. Miller M, Hankinson J, Bruasco V, et al. Standardization of spirometry. Eur Respir J 2005 : 26 : 319 338.
38. Rosenthal M, Bain SH, Cramer D, et al. Lung function in white children aged 4 to 19 years: I-spirometry. Thorax 1993 : 48 : 794 802.
39. Abramson MJ, Walters J, Walters EH. Adverse effects of β-agonists - are they clinically relevant. Am J Respir Med 2003 : 2 : 287 297.
40. O'Connor BJ, Fuller RW, Barnes PJ. Nonbronchodilator effects of inhaled beta 2 agonists: greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1994 : 150 : 381 387.
41. Beach JR, Young CL, Harkawat R, et al. Effect on airway responsiveness of six weeks treatment with salmeterol. Pulm Pharmacol 1993 : 6 : 155 157.
42. Newnham D, Grove A, McDevitt D, et al. Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients. Thorax 1995 : 50 : 475 504.
43. Green SA. Sustained activation of a G-protein-coupled receptor via anchored agonist binding. J Biol Chem 1996 : 271 : 24029 24035.
44. Carroll WD, Lenney W. Drug therapy in the management of acute asthma. Arch Dis Child 2007 : 92 : ep82 6.